
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
School of Public Health and South Carolina Cancer Center, University of South Carolina [W. Z., D-W. X., Q. D., X-O. S.], University of South Carolina School of Medicine and South Carolina Cancer Center [W-Q. W., X-O. S.], Columbia, South Carolina 29203, and Shanghai Cancer Institute, Shanghai 200032, China [F. J., J-R. C., Q. D., Y-T. G.]
Cytochrome P4501B1 (CYP1B1) is a major enzyme catalyzing the formation
of genotoxic 4-hydroxyestradiol. This enzyme is also involved in the
activation of polycyclic aromatic hydrocarbons and heterocyclic
aromatic amines, mammary carcinogens in experimental animals. CYP1B1 is
genetically polymorphic, and the variations in the
CYP1B1 gene may be related to the risk of breast cancer.
We evaluated this hypothesis among 186 breast cancer cases and 200
age-matched controls as part of a large population-based case-control
study conducted in urban Shanghai during 1996 to 1998. Genomic DNA from
cases and controls was analyzed for genetic polymorphism in codon 432
(Val
Leu) of the CYP1B1 gene using a
PCR-RFLP-based assay. The frequency of the Leu allele
was 53% in cases and 46% in controls (P = 0.06).
Compared with those with the Val/Val genotype, women
with the Leu/Leu genotype had a 2.3-fold [95%
confidence interval (CI), 1.24.5] elevated risk of breast cancer
after adjusting for potential confounding variables. This positive
association was more pronounced among postmenopausal women (Odds ratio,
3.1; 95% CI, 1.09.1) than premenopausal women (OR, 1.9; 95% CI,
0.84.3). Elevated risks of breast cancer associated with homozygosity
for the Leu allele were observed in virtually all
subgroups of women defined by major risk factors for breast cancer. The
results from this study were consistent with recent findings from
in vitro and animal experiments implicating a
potentially important role of CYP1B1 in the etiology of human breast
cancer.
This article has been cited by other articles:
![]() |
F D Dick, G De Palma, A Ahmadi, A Osborne, N W Scott, G J Prescott, J Bennett, S Semple, S Dick, P Mozzoni, et al. Gene-environment interactions in parkinsonism and Parkinson's disease: the Geoparkinson study Occup. Environ. Med., October 1, 2007; 64(10): 673 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Cussenot, A. R. Azzouzi, N. Nicolaiew, G. Fromont, P. Mangin, L. Cormier, G. Fournier, A. Valeri, S. Larre, F. Thibault, et al. Combination of Polymorphisms From Genes Related to Estrogen Metabolism and Risk of Prostate Cancers: The Hidden Face of Estrogens J. Clin. Oncol., August 20, 2007; 25(24): 3596 - 3602. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. De Roos, N. Rothman, M. Brown, D. A. Bell, G. S. Pittman, W. R. Shapiro, R. G. Selker, H. A. Fine, P. M. Black, and P. D. Inskip Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors. Neuro-oncol, April 1, 2006; 8(2): 145 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Sissung, D. K. Price, A. Sparreboom, and W. D. Figg Pharmacogenetics and Regulation of Human Cytochrome P450 1B1: Implications in Hormone-Mediated Tumor Metabolism and a Novel Target for Therapeutic Intervention Mol. Cancer Res., March 1, 2006; 4(3): 135 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.S. Wenzlaff, M.L. Cote, C.H. Bock, S.J. Land, S.K. Santer, D.R. Schwartz, and A.G. Schwartz CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study Carcinogenesis, December 1, 2005; 26(12): 2207 - 2212. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Starr, C. Chen, D. R. Doody, L. Hsu, S. Ricks, N. S. Weiss, and S. M. Schwartz Risk of Testicular Germ Cell Cancer in Relation to Variation in Maternal and Offspring Cytochrome P450 Genes Involved in Catechol Estrogen Metabolism Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2183 - 2190. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Le Marchand, T. Donlon, L. N. Kolonel, B. E. Henderson, and L. R. Wilkens Estrogen Metabolism-Related Genes and Breast Cancer Risk: The Multiethnic Cohort Study Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 1998 - 2003. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Aklillu, S. Ovrebo, I. V. Botnen, C. Otter, and M. Ingelman-Sundberg Characterization of Common CYP1B1 Variants with Different Capacity for Benzo[a]pyrene-7,8-Dihydrodiol Epoxide Formation from Benzo[a]pyrene Cancer Res., June 15, 2005; 65(12): 5105 - 5111. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wen, Q. Cai, X.-O. Shu, J.-R. Cheng, F. Parl, L. Pierce, Y.-T. Gao, and W. Zheng Cytochrome P450 1B1 and Catechol-O-Methyltransferase Genetic Polymorphisms and Breast Cancer Risk in Chinese Women: Results from the Shanghai Breast Cancer Study and a Meta-analysis Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 329 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Fowke, X.-O. Shu, Q. Dai, F. Jin, Q. Cai, Y.-T. Gao, and W. Zheng Oral Contraceptive Use and Breast Cancer Risk: Modification by NAD(P)H:Quinone Oxoreductase (NQO1) Genetic Polymorphisms Cancer Epidemiol. Biomarkers Prev., August 1, 2004; 13(8): 1308 - 1315. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zheng, Y.-T. Gao, X.-O. Shu, W. Wen, Q. Cai, Q. Dai, and J. R. Smith Population-Based Case-Control Study of CYP11A Gene Polymorphism and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 709 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. McGrath, S. E. Hankinson, L. Arbeitman, G. A. Colditz, D. J. Hunter, and I. De Vivo Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility Carcinogenesis, April 1, 2004; 25(4): 559 - 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhu, M. R. Spitz, C. I. Amos, J. Lin, M. B. Schabath, and X. Wu An Evolutionary Perspective on Single-Nucleotide Polymorphism Screening in Molecular Cancer Epidemiology Cancer Res., March 15, 2004; 64(6): 2251 - 2257. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Egan, Q. Cai, X.-O. Shu, F. Jin, T.-L. Zhu, Q. Dai, Y.-T. Gao, and W. Zheng Genetic Polymorphisms in GSTM1, GSTP1, and GSTT1 and the Risk for Breast Cancer: Results from the Shanghai Breast Cancer Study and Meta-Analysis Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 197 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Han, D. Kang, I. A. Park, S. W. Kim, J. Y. Bae, K.-W. Chung, and D.-Y. Noh Associations between Breast Cancer Susceptibility Gene Polymorphisms and Clinicopathological Features Clin. Cancer Res., January 1, 2004; 10(1): 124 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Fowke, X.-O. Shu, Q. Dai, A. Shintani, C. C. Conaway, F.-L. Chung, Q. Cai, Y.-T. Gao, and W. Zheng Urinary Isothiocyanate Excretion, Brassica Consumption, and Gene Polymorphisms among Women Living in Shanghai, China Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1536 - 1539. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Zheng, W. Zheng, B.-l. Chang, X.-O. Shu, Q. Cai, H. Yu, Q. Dai, J. Xu, and Y.-T. Gao Joint Effect of Estrogen Receptor {beta} Sequence Variants and Endogenous Estrogen Exposure on Breast Cancer Risk in Chinese Women Cancer Res., November 15, 2003; 63(22): 7624 - 7629. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Cai, X.-O. Shu, F. Jin, Q. Dai, W. Wen, J.-R. Cheng, Y.-T. Gao, and W. Zheng Genetic Polymorphisms in the Estrogen Receptor {alpha} Gene and Risk of Breast Cancer: Results from the Shanghai Breast Cancer Study Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 853 - 859. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Rylander-Rudqvist, S. Wedren, F. Granath, K. Humphreys, S. Ahlberg, E. Weiderpass, M. Oscarson, M. Ingelman-Sundberg, and I. Persson Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk Carcinogenesis, September 1, 2003; 24(9): 1533 - 1539. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Fowke, F.-L. Chung, F. Jin, D. Qi, Q. Cai, C. Conaway, J.-R. Cheng, X.-O. Shu, Y.-T. Gao, and W. Zheng Urinary Isothiocyanate Levels, Brassica, and Human Breast Cancer Cancer Res., July 15, 2003; 63(14): 3980 - 3986. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Dhaini, D. G. Thomas, T. J. Giordano, T. D. Johnson, J. S. Biermann, K. Leu, P. F. Hollenberg, and L. H. Baker Cytochrome P450 CYP3A4/5 Expression as a Biomarker of Outcome in Osteosarcoma J. Clin. Oncol., July 1, 2003; 21(13): 2481 - 2485. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Mammen, G. S. Pittman, Y. Li, F. Abou-Zahr, B. A. Bejjani, D. A. Bell, P. T. Strickland, and T. R. Sutter Single amino acid mutations, but not common polymorphisms, decrease the activity of CYP1B1 against (-)benzo[a]pyrene-7R-trans-7,8-dihydrodiol Carcinogenesis, July 1, 2003; 24(7): 1247 - 1255. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. De Vivo, S. E. Hankinson, L. Li, G. A. Colditz, and D. J. Hunter Association of CYP1B1 Polymorphisms and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., May 1, 2002; 11(5): 489 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
M M de Jong, I M Nolte, G J te Meerman, W T A van der Graaf, J C Oosterwijk, J H Kleibeuker, M Schaapveld, and E G E de Vries Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility J. Med. Genet., April 1, 2002; 39(4): 225 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Aklillu, M. Oscarson, M. Hidestrand, B. Leidvik, C. Otter, and M. Ingelman-Sundberg Functional Analysis of Six Different Polymorphic CYP1B1 Enzyme Variants Found in an Ethiopian Population Mol. Pharmacol., March 1, 2002; 61(3): 586 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Goodman, K. McDuffie, L. N. Kolonel, K. Terada, T. A. Donlon, L. R. Wilkens, C. Guo, and L. Le Marchand Case-Control Study of Ovarian Cancer and Polymorphisms in Genes Involved in Catecholestrogen Formation and Metabolism Cancer Epidemiol. Biomarkers Prev., March 1, 2001; 10(3): 209 - 216. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |